NHS England makes Cancer Drug Cut proposals to prevent £70m over-spend

Posted: 09/07/2015

NHS England has reviewed the arrangement of its Cancer Drug Fund and has announced the de-listing of some life-extending cancer treatments. In a recent announcement NHS England noted that the decision to re-evaluate the treatments listed on the Cancer Drug Fund (CDF) fruited after projections highlighted that unless further prioritisation was

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Posted: 09/07/2015

Pharma IQ Members


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018